{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:00:53Z","timestamp":1792515653247,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. We prospectively evaluated endothelial function by assessing flow-mediated dilatation (FMD) of the brachial artery in patients with biopsy-proven NAFLD. This prospective study included 139 patients (50 healthy controls, 47 patients with steatosis and 42 patients with steatohepatitis), all of whom were nondiabetic. Patients with long-standing or uncontrolled hypertension, smokers, and morbidly obese patients were excluded. The medians (ranges) for vascular FMD in the steatohepatitis, steatosis, and control groups were 6% (0\u201337.5%), 10.8% (0\u201340%) and 13.6% (0\u201350%), respectively. The control group had a higher average FMD than the NAFLD group (15.13% vs 10.46%), and statistical significance was reached when the control and steatohepatitis groups were compared (13.6% vs 6%, p\u2009=\u20090.027). Average alanine aminotransferase was significantly higher in the steatohepatitis group than in the steatosis and control groups (54 (U\/L) vs 31 (U\/L), p\u2009=\u20090.008). Cholesterol levels were similar between all groups. In the multivariate analysis, FMD (OR\u2009=\u20090.85, p\u2009=\u20090.035) and high triglycerides (OR\u2009=\u200976.4, p\u2009=\u20090.009) were significant predictors of steatohepatitis. In the absence of major cardiac risk factors, we demonstrated better endothelial function in healthy controls, evidenced by a higher FMD of the brachial artery than that of patients with steatohepatitis.<\/jats:p>","DOI":"10.1038\/s41598-020-65835-y","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T10:03:14Z","timestamp":1591005794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Endothelial dysfunction in nonalcoholic steatohepatitis with low cardiac disease risk"],"prefix":"10.1038","volume":"10","author":[{"given":"Waleed","family":"Al-hamoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Alsadoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Alkhalidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabih","family":"Halwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Sanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulsalam","family":"Alsharaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Albenmousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Alsaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"issue":"2","key":"65835_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","volume":"132","author":"S Bellentani","year":"2000","unstructured":"Bellentani, S. et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann. Intern. Med. 132(2), 112\u2013117 (2000).","journal-title":"Ann. Intern. Med."},{"key":"65835_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2169\/internalmedicine1962.27.142","volume":"27","author":"H Nomura","year":"1988","unstructured":"Nomura, H. et al. Prevalence of fatty liver in a general population of Okinawa, Japan. Japanese J. Med. 27, 142 (1988).","journal-title":"Japanese J. Med."},{"issue":"8","key":"65835_CR3","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1007\/s10620-013-2659-0","volume":"58","author":"W Al-hamoudi","year":"2013","unstructured":"Al-hamoudi, W. et al. Revising the upper limit of normal for levels of serum alanine aminotransferase in a Middle Eastern population with normal liver histology. Dig. Dis. Sci. 58(8), 2369\u20132375 (2013).","journal-title":"Dig. Dis. Sci."},{"issue":"Suppl 1","key":"65835_CR4","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S1665-2681(19)31822-8","volume":"8","author":"P Almeda-Vald\u00e9s","year":"2009","unstructured":"Almeda-Vald\u00e9s, P., Cuevas-Ramos, D. & Aguilar-Salinas, C. A. Metabolic syndrome and non-alcoholic fatty liver disease. Ann. Hepatol. 8(Suppl 1), S18\u201324 (2009).","journal-title":"Ann. Hepatol."},{"issue":"1","key":"65835_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1464-5491.2007.02025.x","volume":"24","author":"G. Targher","year":"2007","unstructured":"Targher, G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med. 24(1), 1\u20136 (2007).","journal-title":"Diabetic Medicine"},{"issue":"8","key":"65835_CR6","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.2337\/dc07-0349","volume":"30","author":"G. Targher","year":"2007","unstructured":"Targher, G. et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care. 30(8), 2119\u201321 (2007).","journal-title":"Diabetes Care"},{"issue":"6","key":"65835_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/oby.2008.64","volume":"16","author":"Giovanni Targher","year":"2008","unstructured":"Targher, G. et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring). 16(6), 1394\u20139 (2008).","journal-title":"Obesity"},{"issue":"1","key":"65835_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cld.2017.08.011","volume":"22","author":"Alexander J. Kovalic","year":"2018","unstructured":"Kovalic, A. J., Satapathy, S. K. The Role of Nonalcoholic Fatty Liver Disease on Cardiovascular Manifestations and OutcomesClin Liver Dis. 22(1), 141\u2013174 (2018).","journal-title":"Clinics in Liver Disease"},{"key":"65835_CR9","doi-asserted-by":"crossref","unstructured":"Francque, S. M., van der Graaff, D. & Kwanten, W. J. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. J Hepatol. 65(2), 425\u201343 (2016).","DOI":"10.1016\/j.jhep.2016.04.005"},{"key":"65835_CR10","doi-asserted-by":"crossref","unstructured":"Giannitsi, S., Bougiakli, M., Bechlioulis, A. & Naka, K. Endothelial dysfunction and heart failure: A review of the existing bibliography with emphasis on flow mediated dilation. JRSM Cardiovasc Dis. 8, 2048004019843047 (2019).","DOI":"10.1177\/2048004019843047"},{"issue":"16","key":"65835_CR11","doi-asserted-by":"publisher","first-page":"1221 1231","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346(16), 1221 1231 (2002).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"65835_CR12","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/S1665-2681(19)31825-3","volume":"8","author":"J Lizardi-Cervera","year":"2009","unstructured":"Lizardi-Cervera, J. & Aguilar-Zapata, D. Nonalcoholic fatty liver disease and its association with cardiovascular disease. Ann Hepatol. 8(Suppl 1), S40\u20133 (2009).","journal-title":"Ann Hepatol."},{"key":"65835_CR13","doi-asserted-by":"crossref","unstructured":"Messner, B. & Bernhard, D. Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 34(3), 509\u201315 (2014).","DOI":"10.1161\/ATVBAHA.113.300156"},{"key":"65835_CR14","doi-asserted-by":"crossref","unstructured":"Versari, D., Daghini, E., Virdis, A., Ghiadoni, L. & Taddei, S. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br. J. Pharmacol. 157(4), 527\u201336 (2009).","DOI":"10.1111\/j.1476-5381.2009.00240.x"},{"key":"65835_CR15","doi-asserted-by":"publisher","first-page":"S029","DOI":"10.1155\/2007\/326174","volume":"21","author":"W Al-Hamoudi","year":"2007","unstructured":"Al-Hamoudi, W., Alqahtani, S., Ma, M. & Lee, S. S. Hemodynamics in the immediate postoperative period after liver transplantation in alcoholic and postviral cirrhosis. Can J Gastroenterol. 21, S029 (2007).","journal-title":"Can J Gastroenterol."},{"issue":"3","key":"65835_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/1319-3767.65181","volume":"16","author":"WaleedK Al-hamoudi","year":"2010","unstructured":"Al-hamoudi, W. Cardiovascular changes in cirrhosis: pathogenesis and clinical implications. Saudi J. Gastroenterol. 16(3), 145\u201353., https:\/\/doi.org\/10.4103\/1319-3767.65181 (2010).","journal-title":"Saudi Journal of Gastroenterology"},{"key":"65835_CR17","doi-asserted-by":"crossref","unstructured":"Al-hamoudi, W., Lee, S. Cirrhotic Cardiomyoathy. `Ann Hepatol. 5(3), 132\u20139 (2006).","DOI":"10.1016\/S1665-2681(19)31996-9"},{"key":"65835_CR18","doi-asserted-by":"crossref","unstructured":"Memish, Z. A. et al. Obesity and associated factors - kingdom of Saudi Arabia, 2013. Prev Chronic Dis. 11, E174 (2014).","DOI":"10.5888\/pcd11.140236"},{"issue":"6","key":"65835_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.15537\/smj.2019.6.23980","volume":"40","author":"Khalid Alswat","year":"2019","unstructured":"Alswat, K. A. et al. A. Position statement on the diagnosis and management of non-alcoholic fatty liver disease. Saudi Med J. 40(6), 531\u2013540 (2019).","journal-title":"Saudi Medical Journal"},{"key":"65835_CR20","doi-asserted-by":"crossref","unstructured":"Alswat, K. et al. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017\u20132030. Saudi J. Gastroenterol. 24(4), 211\u2013219 (2018).","DOI":"10.4103\/sjg.SJG_122_18"},{"key":"65835_CR21","doi-asserted-by":"crossref","unstructured":"Al-Hamoudi, W. et al. The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool. Hepatol Int. 10(2), 347\u201354 (2016).","DOI":"10.1007\/s12072-015-9664-7"},{"key":"65835_CR22","doi-asserted-by":"crossref","unstructured":"Flammer, A. J. et al. The assessment of endothelial function: from research into clinical practice. Circulation. 126(6), 753\u201367 (2012).","DOI":"10.1161\/CIRCULATIONAHA.112.093245"},{"key":"65835_CR23","doi-asserted-by":"crossref","unstructured":"Donald, A. E. et al. Non-invasive assessment of endothelial function: which technique? J. Am. Coll Cardiol. 48(9), 1846\u201350 (2006).","DOI":"10.1016\/j.jacc.2006.07.039"},{"key":"65835_CR24","unstructured":"Shechter, M. et al. The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease. Isr. Med. Assoc J. 9(4), 271\u20136 (2007)."},{"issue":"1","key":"65835_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.amjmed.2007.08.041","volume":"121","author":"Anna Ludovica Fracanzani","year":"2008","unstructured":"Fracanzani, A. L. et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am. J. Med. 121(1), 72\u20138 (2008).","journal-title":"The American Journal of Medicine"},{"key":"65835_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.20781","volume":"42","author":"N Villanova","year":"2005","unstructured":"Villanova, N., Moscatiello, S. & Ramillis, S. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42, 473\u2013480 (2005).","journal-title":"Hepatology"},{"issue":"3","key":"65835_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1445-5994.2007.01481.x","volume":"38","author":"O. Senturk","year":"2007","unstructured":"Senturk, O. et al. Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease. Intern Med J. 38(3), 183\u20139 (2008).","journal-title":"Internal Medicine Journal"},{"key":"65835_CR28","doi-asserted-by":"crossref","unstructured":"Shechter, M., Shechter, A., Koren-Morag, N., Feinberg, M. S. & Hiersch, L. Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease. Am. J. Cardiol. 113(1), 162\u20137 (2014).","DOI":"10.1016\/j.amjcard.2013.08.051"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65835-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65835-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65835-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:59:53Z","timestamp":1670327993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65835-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65835"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65835-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"26 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8825"}}